AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11332146
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy with cisplatin, 5‐fluorouracil (5‐FU), leucovorin, and interferon‐alpha 2b (PFL‐IFN) followed by concomitant chemoradiation with 5‐FU, hydroxyurea, and total radiotherapy dose of 7000 cGy (FHX)
Trial: 9554570
Drug: Intermittent calcitriol
RxNorm normalized name: Calcitriol
DrugBank: Calcitriol (DB00136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intermittent calcitriol (1,25D) therapy
Trial: 9554570
Drug: Daily 1,25D
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily 1,25D therapy
Trial: 8017327
Drug: Magnesium aspartate-HCl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium aspartate-HCl (20 mmol Mg/d)
Trial: 2472596
Drug: Oral iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral iron therapy (10-day trial)
Trial: 2472596
Drug: Oral iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral iron therapy (3 months)
Trial: 30875390
Drug: Etelcalcetide 5
RxNorm normalized name: etelcalcetide 5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etelcalcetide 5 mg intravenously three times weekly (TIW) after hemodialysis, with potential dose increases of 2.5 or 5 mg at 4-week intervals to a maximum dose of 15 mg TIW.
Trial: 25603851
Drug: Sodium Phosphate
RxNorm normalized name: Sodium Phosphate
DrugBank: Sodium nitrate (DB15952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium Phosphate Tablets (SPT)
Trial: 10710555
Drug: Insulin infusion
RxNorm normalized name: iLet Insulin Infusion 10-Pack Kit Inset
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin infusion (50 mU. kg(‐1). h(‐1))
Trial: 10710555
Drug: Low-dose ANP
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose ANP infusion (0.3 pmol. kg(‐1). h(‐1))
Trial: 10710555
Drug: High-dose ANP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose ANP infusion (2 microg/min)
Trial: 9181268
Drug: Mibefradil (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mibefradil (100 mg daily for 12 weeks)
Trial: 9181268
Drug: Diltiazem CD
RxNorm normalized name: Diltiazem Hydrochloride 300 MG Oral Capsule, Extended Release, 24 HR [DILTIAZEM CD]
DrugBank: Diltiazem (DB00343)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diltiazem CD (360 mg daily for 12 weeks)
Trial: 8474278
Drug: Acarbose (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acarbose (3 x 50 mg/day for 1 month, then 3 x 100 mg/day for 2 months)
Trial: 4078054
Drug: Povidone-iodine-impregnated polyethylene
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Povidone-iodine-impregnated polyethylene oxide gel (PVPI-POG) dressing
Trial: 4078054
Drug: Polyethylene oxide
RxNorm normalized name: Polyethylene Oxide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyethylene oxide gel (POG) dressing
Trial: 29310444
Drug: Galcanezumab 5
RxNorm normalized name: Galcanezumab
DrugBank: Galcanezumab (DB14042)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Galcanezumab 5 mg
Trial: 29310444
Drug: Galcanezumab 50
RxNorm normalized name: Galcanezumab
DrugBank: Galcanezumab (DB14042)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Galcanezumab 50 mg
Trial: 19590158
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of thermal water (TW) for 2 weeks
Trial: 24721352
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline inhalation
Trial: 11943036
Drug: Oral care
RxNorm normalized name: Oral Care Q4 Kit KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral care (tooth brushing after each meal, swabbing with povidone iodine, professional care once a week)
Trial: 11943036
Drug: No oral
RxNorm normalized name: Beano Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No oral care
Trial: 7664863
Drug: Inhaled platelet‐activating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled platelet‐activating factor (PAF) 225 micrograms
Trial: 2673479
Drug: Family therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Family therapy and relatives group (general outcome)
Trial: 23668931
Drug: Sotrastaurin 100
RxNorm normalized name: Sotrastaurin
DrugBank: Sotrastaurin (DB12369)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotrastaurin 100 mg b.i.d. plus standard tacrolimus (sTAC; 5‐12 ng/mL)
Trial: 23668931
Drug: Sotrastaurin 200
RxNorm normalized name: Sotrastaurin
DrugBank: Sotrastaurin (DB12369)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotrastaurin 200 mg b.i.d. plus standard tacrolimus (sTAC; 5‐12 ng/mL)
Trial: 23668931
Drug: Sotrastaurin 300
RxNorm normalized name: Sotrastaurin
DrugBank: Sotrastaurin (DB12369)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotrastaurin 300 mg b.i.d. plus reduced tacrolimus (rTAC; 2‐5 ng/mL)
Trial: 23668931
Drug: Enteric-coated mycophenolic
RxNorm normalized name: mycophenolic acid
DrugBank: Mycophenolic acid (DB01024)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enteric-coated mycophenolic acid (MPA) plus standard tacrolimus (sTAC; 5‐12 ng/mL)
Trial: 23668931
Drug: Sotrastaurin 200
RxNorm normalized name: Sotrastaurin
DrugBank: Sotrastaurin (DB12369)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotrastaurin 200 mg and 300 mg
Trial: 23668931
Drug: Sotrastaurin (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotrastaurin (all doses)
Trial: 18436117
Drug: Pravastatin 40
RxNorm normalized name: pravastatin 40 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin 40 mg/day (prava40)
Trial: 18436117
Drug: Atorvastatin 10
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10 mg/day (atorva10)
Trial: 18436117
Drug: Atorvastatin 80
RxNorm normalized name: atorvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 80 mg/day (atorva80)
Trial: 10857523
Drug: Moderate exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate exercise using arm and bicycle ergometers performed twice a day, 5 times a week, for 14 days, at 60% of maximal heart rate.
Trial: 8254142
Drug: Light treatment
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Light treatment administered at the first signs of winter depression
Trial: 31276886
Drug: Glyphosate (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glyphosate (1 mg/L)
Trial: 31276886
Drug: Roundup (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roundup (1 mg/L of glyphosate a.e.)
Trial: 31276886
Drug: Roundup (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roundup (1 mg/L of glyphosate a.e.) with androgenic gland
Trial: 27738796
Drug: Ondansetron 32-mg
RxNorm normalized name: Ondansetron
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ondansetron 32-mg infusion over 24 hours
Trial: 27738796
Drug: Olanzapine wafer
RxNorm normalized name: Olanzapine
DrugBank: Olanzapine (DB00334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olanzapine wafer 10 mg once daily plus ondansetron 8 mg IV three times a day
Trial: 27738796
Drug: Palonosetron 0.25
RxNorm normalized name: palonosetron 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palonosetron 0.25 mg IV
Trial: 25894123
Drug: Sirolimus +
RxNorm normalized name: Sirolimus
DrugBank: Sirolimus (DB00877)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Sirolimus + cyclosporine + prednisolone for 3 months followed by sirolimus + prednisolone + mycophenolate mofetil with steroid minimization
Trial: 23136856
Drug: Oral miltefosine
RxNorm normalized name: Miltefosine
DrugBank: Miltefosine (DB09031)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral miltefosine (100 mg/day for 12 weeks)
Trial: 23136856
Drug: Oral miltefosine
RxNorm normalized name: Miltefosine
DrugBank: Miltefosine (DB09031)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral miltefosine (100 mg/day for 8 weeks)
Trial: 9422899
Drug: Ketoprofen 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen 2.0 mg kg-1 i.v.
Trial: 9422899
Drug: Ketoprofen 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen 0.5 mg kg-1 i.v.
Trial: 8290458
Drug: OAD cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OAD cream
Trial: 20444751
Drug: Initial combination
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial combination therapy with methotrexate (MTX) and ciclosporin (CSA), n=80
Trial: 20444751
Drug: Initial monotherapy
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial monotherapy with methotrexate (MTX), n=80
Trial: 20444751
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment groups (MTX + CSA and MTX)
Trial: 18635500
Drug: 0.25% bupivacaine
DrugBank: Bupivacaine (DB00297)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 0.25% bupivacaine and 100 mg tramadol (group BT)
Trial: 18635500
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg tramadol (group T)
Trial: 12392384
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 250 microg administered once daily
Trial: 8611112
Drug: Active loperamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active loperamide suppositories (20 mg b.d. x 1 week)
Trial: 2167791
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of atrial natriuretic factor at doses of 0.5, 2 and 10 pmol min‐1 kg‐1
Trial: 2167791
Drug: Intravenous infusion
RxNorm normalized name: intravenous infusion pump accessory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous infusion of atrial natriuretic factor at a pharmacological dose of 50 pmol min‐1 kg‐1
Trial: 6944146
Drug: Viral oncolysate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Viral oncolysate (formalin-treated fowl plaque virus-infected allogenous leukemia cells) in addition to maintenance chemotherapy
Trial: 21593672
Drug: i-gel (novices)
RxNorm normalized name: IOBENGUANE I 123
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i-gel (novices)
Trial: 21593672
Drug: i-gel (experienced)
RxNorm normalized name: IOBENGUANE I 123
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i-gel (experienced)
Trial: 17683540
Drug: Coxibs (cyclooxygenase-2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coxibs (cyclooxygenase-2 selective inhibitors)
Trial: 10410789
Drug: lodoxamide tromethamine
RxNorm normalized name: Lodoxamide Tromethamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lodoxamide tromethamine 0.1% ophthalmic solution
Trial: 31860383
Drug: Refrigerated formulation
RxNorm normalized name: Refrigerant 114
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Refrigerated formulation (RF) of VGX-3100
Trial: 31860383
Drug: Frozen formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frozen formulation (FF) of VGX-3100
Trial: 26134388
Drug: Flaxseed mucilage
RxNorm normalized name: FLAXSEED
DrugBank: Flax seed (DB10708)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed mucilage (10 g)
Trial: 26134388
Drug: L. paracasei
RxNorm normalized name: L. paracasei/L. rhamnosus 11 billion cell ORAL CAPSULE
DrugBank: Lactobacillus paracasei (DB16551)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L. paracasei F19 (9.4 × 10^10 colony-forming units)
Trial: 7547041
Drug: Lower limb
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower limb IVRA with 0.1 mg of HIDA labelled with 100 muCi of 99mTc in 40 ml of saline; tourniquet inflated for 20 min.
Trial: 7547041
Drug: Upper limb
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Upper limb IVRA with 0.1 mg of HIDA labelled with 100 muCi of 99mTc in 40 ml of saline; tourniquet inflated for 20 min.
Trial: 6122738
Drug: Ranitidine hydrochloride
RxNorm normalized name: Ranitidine Hydrochloride
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine hydrochloride 200mg twice daily for six weeks
Trial: 6122738
Drug: Ranitidine hydrochloride
RxNorm normalized name: Ranitidine Hydrochloride
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine hydrochloride 100mg at night for one year as maintenance treatment
Trial: 28475678
Drug: Creatine (20 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine (20 g/day load×5 days followed by 2 g/day orally)
Trial: 18000538
Drug: SP plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SP plus azithromycin (1 g/day x 2 days)
Trial: 18000538
Drug: SP plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SP plus artesunate (200 mg/day x 3 days)
Trial: 18000538
Drug: sulfadoxine-pyrimethamine (SP;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sulfadoxine-pyrimethamine (SP; 3 tablets, 500 mg sulfadoxine and 25 mg pyrimethamine per tablet)
Trial: 8043996
Drug: Ligustrazine 160
RxNorm normalized name: LIGUSTRAZINE
DrugBank: Ligustrazine (DB19074)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ligustrazine 160 mg intravenously for 10 days
Trial: 31898939
Drug: Reduced-dose tacrolimus
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reduced-dose tacrolimus with standard-dose mycophenolate mofetil (MMF)
Trial: 31898939
Drug: Standard-dose tacrolimus
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard-dose tacrolimus with reduced-dose mycophenolate mofetil (MMF)
Trial: 27151255
Drug: Eltrombopag (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eltrombopag (up to 75 mg/day) for 7 or 13 weeks
Trial: 27151255
Drug: Eltrombopag (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eltrombopag (up to 75 mg/day)
Trial: 27151255
Drug: Eltrombopag (open-label
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eltrombopag (open-label treatment for ≥24 weeks)
Trial: 21079428
Drug: Isoniazid preventive
RxNorm normalized name: Isoniazid
DrugBank: Isoniazid (DB00951)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isoniazid preventive therapy (IPT) with HAART
Trial: 18434189
Drug: Escitalopram (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram (20 mg/day) + Naltrexone (50 mg/day)
Trial: 18434189
Drug: Escitalopram (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram (20 mg/day) + GHB (75 mg/kg)
Trial: 18434189
Drug: Escitalopram (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram (20 mg/day) + Naltrexone (50 mg/day) + GHB (75 mg/kg)
Trial: 12660585
Drug: 1% carteolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% carteolol alginate once daily
Trial: 12660585
Drug: 1% carteolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% carteolol standard solution twice daily
Trial: 8097273
Drug: Fluconazole (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole (150 mg oral dose, once a week)
Trial: 3513516
Drug: Instant and
RxNorm normalized name: Advanced Eye Relief Redness Instant Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Instant and sustained-release verapamil
Trial: 3513516
Drug: Verapamil (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (all formulations)
Trial: 28074135
Drug: Aclidinium 400
RxNorm normalized name: aclidinium 400 mcg/inh inhalation powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aclidinium 400 µg twice daily
Trial: 22142458
Drug: 100 ml
RxNorm normalized name: PVC IV Bag 100 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 ml vodka (30 g alcohol) with 200 ml orange juice
Trial: 16103605
Drug: Praziquantel (offered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Praziquantel (offered to individuals uncured after two myrrh treatments)
Trial: 11941903
Drug: Antihypertensive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive treatment in women
Trial: 11941903
Drug: Antihypertensive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive treatment in men
Trial: 11941903
Drug: One drug
RxNorm normalized name: mometasone Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One drug treatment
Trial: 11941903
Drug: Fixed combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed combination therapy
Trial: 11941903
Drug: Free combination
RxNorm normalized name: SUNSCREEN-29 PABA-FREE COMBINATION LOT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Free combination therapy
Trial: 11941903
Drug: ACE inhibitors/AT‐II
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitors/AT‐II antagonists
Trial: 10024093
Drug: Resistant starch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistant starch supplements
Trial: 8636524
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of liquid 5% lidocaine
Trial: 8636524
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of 2% lidocaine paste
Trial: 2149050
Drug: Vancomycin (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vancomycin (30 mg/kg/d)
Trial: 2149050
Drug: Teicoplanin (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teicoplanin (6 mg/kg every 12 h on day 1, then daily)
Trial: 398661
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg domperidone I.V.
Trial: 398661
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg domperidone I.V.
Trial: 31923565
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g kg‐1 Fishwort Powder (FWP)
Trial: 31094461
Drug: Umifenovir (Arbidol)
RxNorm normalized name: umifenovir
DrugBank: Umifenovir (DB13609)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Umifenovir (Arbidol) 800 mg/day for 5 days (n=181)
Trial: 26118077
Drug: Homotoxicological medicines
RxNorm normalized name: Percy Medicine
DrugBank: Bismuth subsalicylate (DB01294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Homotoxicological medicines (Lymphomyosot, Galium‐Heel®, Traumeel S, Echinacea compositum S, Bronchalis‐Heel®, Mucosa compositum) in addition to standard anti‐inflammatory therapy
Trial: 26118077
Drug: Standard anti‐inflammatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard anti‐inflammatory therapy
Trial: 21996132
Drug: Dexfenfluramine 40
RxNorm normalized name: dexfenfluramine
DrugBank: Dexfenfluramine (DB01191)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexfenfluramine 40 mg (n = 6)
Trial: 21996132
Drug: Dexfenfluramine 60
RxNorm normalized name: dexfenfluramine
DrugBank: Dexfenfluramine (DB01191)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexfenfluramine 60 mg (n = 7)
Trial: 21996132
Drug: Dexfenfluramine (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexfenfluramine (both doses)
Trial: 17719273
Drug: Maximal in-hospital
RxNorm normalized name: Spirulina maxima preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maximal in-hospital diuretic dose
Trial: 15808387
Drug: Oxybutynin starting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxybutynin starting dose of 2.5 mg bd
Trial: 15808387
Drug: Oxybutynin starting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxybutynin starting dose of 5 mg nocte
Trial: 9448164
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg once daily, amoxicillin 500 mg t.i.d., metronidazole 500 mg t.i.d.
Trial: 9448164
Drug: Amoxicillin 500
RxNorm normalized name: amoxicillin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin 500 mg t.i.d., metronidazole 500 mg t.i.d.
Trial: 2121360
Drug: Selegiline (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selegiline (10 mg tablets once daily)
Trial: 2121360
Drug: Phosphatidylserine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phosphatidylserine (100 mg capsules twice daily)
Trial: 20035984
Drug: 200 U
RxNorm normalized name: lipase 1200 UNT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 U BTX‐A initially, with subsequent injections between 100 and 300 U
Trial: 20035984
Drug: Dose alteration
RxNorm normalized name: SLICK ALTERATION DISRUPTING BOS TAURUS G.(NC_037347.1) FS(39099129-39099368) IN EXON 9 OF PRLR GENE IN BOS TAURUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose alteration in BTX‐A
Trial: 20035984
Drug: Repeated injections
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated injections of BTX‐A
Trial: 15758796
Drug: Tolterodine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolterodine (2 mg daily)
Trial: 10966890
Drug: Lipid emulsion
RxNorm normalized name: propofol lipid emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid emulsion (10% triacylglycerol emulsion) + heparin (200 U bolus followed by 0.2 U*min(‐)(1)*kg body wt(‐)(1)) for 180 min
Trial: 10966890
Drug: Lipid emulsion
RxNorm normalized name: propofol lipid emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid emulsion + heparin with propranolol infusion (n = 8)
Trial: 8828369
Drug: Aprotinin high-dose
RxNorm normalized name: Aprotinin
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aprotinin high-dose (300 x 10^4 units)
Trial: 8828369
Drug: Aprotinin low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Aprotinin low-dose (100 x 10^4 units)